Advertisement

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literaturverzeichnis

  1. Abedi H, Dawes KE, Zachary I: Differential effects of platelet-derived growth factor BB on p125 focal adhesion kinase and paxillin tyrosine phosphorylation and on cell migration in rabbit aortic vascular smooth muscle cells and Swiss 3T3 fibroblasts. J Biol Chem 1995;270:11367–76PubMedCrossRefGoogle Scholar
  2. Adachi S, Ito H, Akimoto H, Tanaka M, Fujisaki H, Marumo F, Hiroe M: Insulin-like growth factor-II induces hypertrophy with increased expression of muscle specific genes in cultured rat cardiomyocytes. J Mol Cell Cardiol 1994;26:789–95PubMedCrossRefGoogle Scholar
  3. Ashizawa N, Graf K, Do Y, Nunohiro T, Giachelli C, Meehan W, Tuan T, Hsueh WA: Osteopontin is produced by rat cardiac fibroblasts and mediates All-induced DNA synthesis and collagen gel contraction. J Clin Invest 1996;98:2218–2227PubMedCrossRefGoogle Scholar
  4. Baker K, Booz G, Dostal D: Cardiac actions of angiotensin II: Role of an intracardiac reninangiotensin system. Annu.Rev.Physiol. 1992;54:227–241PubMedCrossRefGoogle Scholar
  5. Baker K, Chernin M, Wixson S, Aceto J: Renin-angiotensin system involvement in pressure overloaded cardiac hyperthrophy in rats. Am J Physiol. 1990;259:H324–H332PubMedGoogle Scholar
  6. Baker KM, Aceto JF: Angiotensin II stimulation of protein synthesis and cell growth in chick heart cells. Am J Physiol. 1990;259:H610–8PubMedGoogle Scholar
  7. Ballingand JL, Cannon PJ: Nitric oxide synthases and cardiac muscle. Autocrine and paracrine influences. Arterioscler. Thromb. Vasc. Biol. 1997;17:1846–1858CrossRefGoogle Scholar
  8. Behrend EI, Craig AM, Wilson SM, Denhardt DT, Chambers AF: Reduced malignancy of ras-transformed NIH 3T3 cells expressing antisense osteopontin RNA. Cancer Res 1994;54:832–7PubMedGoogle Scholar
  9. Beninati S, Senger S, Cordella-Miele E, Mukherjee A, Chackala-Parampil I, Shangunam V, Singh K, Mukherjee B: Osteopontin: its transglutaminase-catalyzed posttranslational modifcations and crosslinking to fibronectin. J Biochem 1994;115:675–682PubMedGoogle Scholar
  10. Bikkina M, Larson MG, Levy D: Asymptomatic ventricular arrhythmias and mortality risk in subjects with left ventricular hypertrophy. J Am Coll Cardiol 1993;22:1111–6PubMedCrossRefGoogle Scholar
  11. Bird IM, Mason JI, Rainey WE: Regulation of type 1 angiotensin II receptor messenger ribonucleic acid expression in human adrenocortical carcinoma H295 cells. Endocrinology 1994;134:2468–2474PubMedCrossRefGoogle Scholar
  12. Boluyt MO, O’Neill L, Meredith AL, Ring OHL, Brooks WW, Conrad CH, Crow MT, Lakatta EG: Alterations in cardiac gene expression during the transition from stable hypertrophy to heart failure. Circ Res 1994;75:25–32Google Scholar
  13. Brilla CG, Janicki JS, Weber KT: Cardioreparative effects of lisinopril in rats with genetic hypertension and left ventricular hypertrophy. Circulation 1991;83:1771–9PubMedGoogle Scholar
  14. Brilla CG, Zhou G, Matsubara L, Weber KT: Collagen metabolism in cultured adult rat cardiac fibroblasts: response to angiotensin II and aldosterone. J Mol Cell Cardiol 1994;26:809–20 Brooks PC, Clark R, Cheresh DA: Requirement of vascular integrin αvβ3 for angiogenesis. Science 1994;264:569–571CrossRefGoogle Scholar
  15. Brooks PC, Stromblad S, Sanders LC, von Schalscha TL, Aimes RT, Stetler-Stevenson WG, Quigley JP, Cheresh DA: Localization of matrix metalloproteinase MMP-2 to the surface of invasive cells by interaction with integrin alpha v beta 3. Cell 1996. 85: 683–93.PubMedCrossRefGoogle Scholar
  16. Bruckschlegel G, Holmer SR, Jandeleit K, Grimm D, Muders F, Kromer EP, Riegger GA, Schunkert H: Blockade of the renin-angiotensin system in cardiac pressure-overload hypertrophy in rats. Hypertension 1995, 25: 250–9.PubMedGoogle Scholar
  17. Brown LF, Berse B, Van de Water L, Papadopoulos Sergiou A, Perruzzi CA, Manseau EJ, Dvorak HF, Senger DR: Expression and distribution of osteopontin in human tissues: widespread association with luminal epithelial surfaces. Mol Biol Cell 1992;3:1169–80PubMedGoogle Scholar
  18. Buchanan T, Sipos G, Gadallah S, Yip K, Marsh D, Hsueh WA, Bergman R: Glucose tolerance and insulin actions in rats with renovascular hypertension. Hypertension 1991;18:341–347PubMedGoogle Scholar
  19. Burgess ML, Carver WE, Terracio L, Wilson SP, Wilson MA, Borg TK: Integrin-mediated collagen gel contraction by cardiac fibroblasts. Effects of angiotensin II. Circ Res 1994;74:291–8PubMedGoogle Scholar
  20. Burgess ML, Buggy J, Price RL, Abel FL, Terracio L, Samarel AM, Borg TK. Exercise- and hypertension-induced collagen changes are related to left ventricular function in rat hearts. Am J Physiol 1996 270: H151–9Google Scholar
  21. Calalb MB, Polte TR, Hanks SK: Tyrosine phosphorylation of focal adhesion kinase at sites in the catalytic domain regulates kinase activity: a role for Src family kinases. Mol Cell Biol 1995;15:954–63PubMedGoogle Scholar
  22. Caulfield JB: Alterations in cardiac collagen with hypertrophy, pp 49–57. In Tarazi RC, Dunbar JB (eds): Perspectivesin cardiovascular research. Vol.8. Lippincott-Raven, Philadelphia 1983;Google Scholar
  23. Center of GISSI -3: Effects of lisinopril and transdermal glyceryl trinitrate singly and together on 6-week mortality and ventricular function after acute myocardial infarction. Lancet 1994;343:1115–1122Google Scholar
  24. Chen Q, Kinch MS, Lin TH, Burridge K, Juliano RL: Integrin-mediated cell adhesion activates mitogen-activated protein kinases. J Biol Chem 1994;269:26602–5PubMedGoogle Scholar
  25. Chen Q, Lin TH, Der CJ, Juliano RL: Integrin-mediated activation of MEK and mitogen-activated protein kinase is independent of Ras. J Biol Chem 1996;271:18122–7PubMedCrossRefGoogle Scholar
  26. Choi E, Engel L, Callow A: Inhibition of neointimal hyperplasia by blocking αvβ3 integrin with a small peptide antagonist GpenGRGDSPCA. J Vasc Surg 1994;19:124–134CrossRefGoogle Scholar
  27. Chomczynski P, Sacchi N: Single step method of RNA isolation by acid guanidinium hemocyanate-phenol-chloroform extraction. Analytical Biochem 1989;162:156–159CrossRefGoogle Scholar
  28. Clark EA, Brugge JS: Integrins and signal transduction pathway: the road taken. Science 1995;268:233–239PubMedCrossRefGoogle Scholar
  29. Clark EA, Brugge JS: Redistribution of activated pp60c_scr to integrin dependent cytoskeletoal complexes in thrombin stimulated platelets. Mol.Cell Biol. 1993;13:1863–1871PubMedGoogle Scholar
  30. Crawford D, Chobanian A, Brecher P: Angiotensin II induces fibronectin expression associated with cardiac fibrosis in the rat. Circ. Res. 1994;74:727–739PubMedGoogle Scholar
  31. Dahloef B, Pennert K, Hansson L: Reversal of left ventricular hyperthrophy in hypertensive patients. A metaanalysis of 109 treatment studies. Am J Hypertension 1992;5:95–110Google Scholar
  32. Davies J, Warwick J, Totty N, Philp R, Helfrich M, Horton M: The osteoclast functional antigen implicated in the regulation of bone resorption is biochemically related to the vitronectin receptor. J Cell Biol 1989;109:1817–1826PubMedCrossRefGoogle Scholar
  33. Denhardt DT, Guo X: Osteopontin: a protein with diverse functions. Faseb J 1993;7:1475–82PubMedGoogle Scholar
  34. Dickstein K, Chang P, Willenheimer R, Haunso S, Remes J, Hall C, Kjekshus J: Comparison of the effects of losartan and enalapril on clinical status and exercise performance in patients with moderate or severe chronic heart failure. J Am Coll Cardiol 1995;26:438–45PubMedCrossRefGoogle Scholar
  35. Dike LE, Farmer SR: Cell adhesion induces expression of growth-associated genes in suspension-arrested fibroblasts. Proc Natl Acad Sci USA 1988;85:6792–6PubMedCrossRefGoogle Scholar
  36. Ertl G, Gaudron P, Kochsiek K: Influence of angiotensin-converting enzyme inhibition on cardiac function in myocardial infarction. Am J Cardiol 1990.1 65: 70G-73G.CrossRefGoogle Scholar
  37. Fisher S, Absher M: Norepinephrine and ANG II stimulate secretion of TGF-ß by neonatal rat cardiac fibroblasts in vitro. Am J Physiol. 1995;268:C910–C917PubMedGoogle Scholar
  38. Fraccarollo D, Hu K, Galuppo P, Gaudron P, Ertl G: Chronic endothelin receptor blockade attenuates progressive ventricular dilation and improves cardiac function in rats with myocardial infarction: possible involvement of myocardial endothelin system in ventricular remodeling. Circulation 1997, 96: 3963–73.PubMedGoogle Scholar
  39. Fry DL, Griggs DM, Greenfield JC: Myocardial mechanics. Tension-velocity-length relationsships of heart muscle. Circ Res 1964;14:73–78PubMedGoogle Scholar
  40. Gardner HA, Berse B, Senger DR: Specific reduction in osteopontin synthesis by antisense RNA inhibits the tumorigenicity of transformed Rat1 fibroblasts. Oncogene 1994;9:2321–6PubMedGoogle Scholar
  41. Giacchelli CM, Bae N, Almeida M, Denhard D, Alpers C, Schwartz SM: Osteopontin expression is elevated during neointima formation in rat artereies and in human atherosclerosis plaques. J Clin Invest 1993;92:1686–1696CrossRefGoogle Scholar
  42. Giachelli CM, Bae N, Lombardi D, Majesky M, Schwartz SM: Molecular cloning and characterization of 2B7, a rat mRNA which distinguishes smooth muscle cell phenotypes in vitro and is identical to osteopontin (secreted phosphoprotein I, 2aR). Biochem Biophys Res Commun 1991; 177:867–73PubMedCrossRefGoogle Scholar
  43. Giachelli CM, Pichler R, Lombardi D, Denhardt DT, Alpers CE, Schwartz SM, Johnson RJ: Osteopontin expression in angiotensin II-induced tubulointerstitial nephritis. Kidney Int 1994;45:515–24PubMedCrossRefGoogle Scholar
  44. Graf K, Do YS, Ashizawa N, Meehan WP, Giachelli CM, Marboe CC, Fleck E, Hsueh WA: Myocardial osteopontin expression is associated with left ventricular hypertrophy. Circulation 1997;96:3063–71PubMedGoogle Scholar
  45. Graf K, Koehne P, Gräfe M, Zhang M, Auch-Schwelk W, Fleck E. Regulation and differential expression of neutral endopeptidase 24.11 in human endothelial cells. Hypertension 1995, 26: 230–235PubMedGoogle Scholar
  46. Graf K, Kunkel K, Zhang M, Gräfe M, Koehne P, Schudt C, Biroc P, Fleck E, Kunkel G. Activation of adenylate cyclase and phosphodiesterase inhibition enhance neutral endopeptidase-activity in human endothelial cells. Peptides 1995, 16: 1273–1278PubMedCrossRefGoogle Scholar
  47. Graf K, Xi XP, Yang D, Fleck E, Law RE, Hsueh WA. MAP Kinase-activation is involved in PDGF-directed migration by vascular smooth muscle cells. Hypertension 1997, 29(part 2): 334–339PubMedGoogle Scholar
  48. Gräfe M, Bossaller C, Graf K, Auch-Schwelk W, Baumgarten C, Hildebrandt A, Fleck E: Effect of angiotensin converting enzyme inhibition on bradykinin metabolism by human vascular endothelial cells. Am J Physiol 1993;33, 264:H1493–1497.Google Scholar
  49. Guadagno TM, Ohtsubo M, Roberts JM, Assoian RK: A link between cyclin A expression and adhesion-dependent cell cycle progression. Science 1993;262:1572–5PubMedCrossRefGoogle Scholar
  50. Guidry C, Grinnell F: Contraction of hydrated collagen gels by fibroblasts: evidence for two mechanisms by which collagen fibrils are stabilized. Collagen Rel Res 1986;6:515–529.Google Scholar
  51. Gullberg D, Turner DC, Borg TK, Terracio L, Rubin K: Different beta 1-integrin collagen receptors on rat hepatocytes and cardiac fibroblasts. Exp Cell Res 1990;190:254–64PubMedCrossRefGoogle Scholar
  52. Harpold M, Evans R, Saidtt-Georgieff M,Darnell J: Production of mRNA in Chinese hamster cells; relationship of the rate of synthesis to the cytoplasmic concentration of nine specific mRNA sequences. Cell 1979;17:1025–1035PubMedCrossRefGoogle Scholar
  53. Heino J, Ignotz RA, Hemler ME, Crouse C, Massague J: Regulation of cell adhesion receptors by transforming growth factor-ß. J Biol Chem. 1989;264:380–386PubMedGoogle Scholar
  54. Helfrich MH, Nesbitt SA, Dorey EL, Horton MA: Rat osteoclasts adhere to a wide range of RGD (Arg-Gly-Asp) peptide-containing proteins, including the bone sialoproteins and fibronectin, via a beta 3 integrin. J Bone Miner Res 1992;7:335–43PubMedCrossRefGoogle Scholar
  55. Hirota S, Imakita M, Kohri K, Ito A, Morii E, Adachi S, Kim HM, Kitamura Y, Yutani C, Nomura S: Expression of osteopontin messenger RNA by macrophages in atherosclerotic plaques. A possible association with calcification. Am J Pathol 1993;143:1003–8PubMedGoogle Scholar
  56. Hirsch A, Talsness C, Schunkert H, Paul M, Dzau V: Tissue specific activation of cardiac angiotensin converting enzyme in experimental heart failure. Circ Res 1991;69:475–482PubMedGoogle Scholar
  57. Holtz J: The cardiac renin-angiotensin system: physiological relevance and pharmacological modulation. Clin Investig 1993; 71: S25–34.PubMedCrossRefGoogle Scholar
  58. Holtz J, Goetz RM: 1994. Vascular renin-angiotensin-system, endothelial function and atherosclerosis? Basic Res Cardiol 1994; 1: 71–86.Google Scholar
  59. Hou J, Kato J, Cohen R, Chobanian A, Brecher P: Angiotensin II-induced cardiac fibrosis in the rat is increased by chronic inhibition of nitric oxide synthase. J Clin Invest 1995;96:2469–2477PubMedCrossRefGoogle Scholar
  60. Hsu S, Raine L, Fanger H: The use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures. J Histochem Cytochem 1981;29:557–564Google Scholar
  61. Hsueh WA, Law RE, Do YS: Integrins, adhesion, and cardiac remodeling. Hypertension 1998;31:176–80PubMedGoogle Scholar
  62. Hughes J, Roth RH: Evidence that angiotensin enhances transmitter release during sympathetic nerve stimulation. Br J Pharmacol. 1971;41:239–245PubMedGoogle Scholar
  63. Huttenlocher A, Werb Z, Tremble P, Huhtala P, Rosenberg L, Damsky CH: Decorin regulates collagenase gene expression in fibroblasts adhering to vitronectin. Matrix Biol 1996;15:239–50PubMedCrossRefGoogle Scholar
  64. Hynes R: Integrins: versatility, modulation and signaling in cell adhesion. Cell 1992;69:11–25PubMedCrossRefGoogle Scholar
  65. Ikeda T, Shirasawa T, Esaki Y, Yoshiki S, Hirokawa K: Osteopontin mRNA is expressed by smooth muscle-derived foam cells in human atherosclerotic lesions of the aorta. J Clin Invest 1993;92:2814–20PubMedCrossRefGoogle Scholar
  66. Ilic D, Furuta Y, Kanazawa S, Takeda N, Sobue K, Nakatsuji N, Nomura S, Fujimoto J, Okada M, Yamamoto T: Reduced cell motility and enhanced focal adhesion contact formation in cells from FAK-deficient mice. Nature 1995;377:539–44PubMedCrossRefGoogle Scholar
  67. Investigators-SAVE: Effect of enalapril on mortality and development of heart failure in asymptomatic patients with reduced left ventricular ejection fraction. N Engl J Med 1992;327:685–691CrossRefGoogle Scholar
  68. Ito H, Hirata Y, Adachi S, Tanaka M, Tsunijo M, Koike A, Nogami A, Marumo F, Hiroe M: Endothelin-1 is an autocrine/paracrine factor in the mechanism of angiotensin II-induced hyperthrophy in cultured rat cardiomyocytes. J Clin Invest 1993;92:398–403PubMedCrossRefGoogle Scholar
  69. Iwai NY, Yamano S, Chaki S, Konishi R, Bardhan S, Tibbetts C, Sasaki K, Sasegawa M, Matsuda Y, Inagami T: Rat angiotensin II receptor cDNA sequence and regulation of the gene expression. Biochem Biophys Res Commun 1991;177:299–304PubMedCrossRefGoogle Scholar
  70. Iwami K, Ashizawa N, Yung S, Graf K, Hsueh WA: Comparison of angiotensin II with other growth factors on EGR-1 and matrix gene expression in cardiac fibroblasts. Am. J. Physiol. 1996;270:H 2100–2107Google Scholar
  71. Juliano RL, Haskill S: Signal transduction from the extracellular matrix. J Cell Biol 1993;120:577–85PubMedCrossRefGoogle Scholar
  72. Kannel WB, Belanger AJ: Epidemiology of heart failure. Am. Heart J. 1991;121:951–957PubMedCrossRefGoogle Scholar
  73. Kariya K, Karns LR, Simpson PC: An enhancer core element mediates stimulation of the rat beta-myosin heavy chain promoter by an alpha 1-adrenergic agonist and activated beta-protein kinase C in hypertrophy of cardiac myocytes. J. Biol. Chem 1994;269:3775–82PubMedGoogle Scholar
  74. Karns LR, Kariya K, Simpson PC: M-CAT, CArG, and Sp1 elements are required for alpha 1-adrenergic induction of the skeletal alpha-actin promoter during cardiac myocyte hypertrophy. Transcriptional enhancer factor-1 and protein kinase C as conserved transducers of the fetal program in cardiac growth. J Biol Chem 1995;270:410–7PubMedCrossRefGoogle Scholar
  75. Kasugai S, Zhang Q, Overall CM, Wrana JL, Butler WT, Sodek J: Differential regulation of the 55 and 44 kDa forms of secreted phosphoprotein 1 (SPP-1, osteopontin) in normal and transformed rat bone cells by osteotropic hormones, growth factors and a tumor promoter. Bone Miner 1991;13:235–50PubMedCrossRefGoogle Scholar
  76. Kim S, Ohta K, Hamaguchi A, Omura T, Yukimura T, Miura K, Inada Y, Ishimura Y, Chatani F, Iwao H: Angiotensin II type 1 receptor antagonist inhibits the gene expression of transforming growth factor –ß1 and extracellular matrix in cardiac and vascular tissues of hypertensive rats. J Pharmacol Exp Ther 1995;273:509–515PubMedGoogle Scholar
  77. Knowlton AA, Connelly CM, Romo GM, Mamuya W, Apstein CS, Brecher P: Rapid expression of fibronectin in the rabbit heart after myocardial infarction with and without reperfusion. J Clin Invest 1992;89:1060–8PubMedCrossRefGoogle Scholar
  78. Komuro I, Yazaki Y: Control of cardiac gene expression by mechanical stress. Annu Rev Physiol 1993;55:55–75PubMedCrossRefGoogle Scholar
  79. Kromer EP, Riegger GA: Effects of long-term angiotensin converting enzyme inhibition on myocardial hypertrophy in experimental aortic stenosis in the rat. Am J Cardiol 1988;62:161–3PubMedCrossRefGoogle Scholar
  80. Lang RM, Elkayam U, Yellen LG, Krauss D, McKelvie RS, Vaughan DE, Ney DE, Makris L, Chang PI: Comparative effects of losartan and enalapril on exercise capacity and clinical status in patients with heart failure. The Losartan Pilot Exercise Study Investigators. J Am Coll Cardiol 1997;30:983–91PubMedCrossRefGoogle Scholar
  81. Leavesly D, Schwartz M, Rosenfeldt M, Cheresh D: Integrin ß1 and ß3-mediated endothelial cell migration is triggered through distinct signaling mechanisms. J Biol Chem 1993;121:163–170Google Scholar
  82. Levy D, Anderson KM, Savage DD, Balkus SA, Kannel WB, Castelli WP: Risk of ventricular arrhythmias in left ventricular hypertrophy: the Framingham Heart Study. Am J Cardiol 1987;60:560–5PubMedCrossRefGoogle Scholar
  83. Levy D, Garrison RJ, Savage DD, Kannel WB, Castelli WP: Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study [see comments]. N Engl J Med 1990;322:1561–6PubMedCrossRefGoogle Scholar
  84. Liaw L, Almeida M, Hart CE, Schwartz SM, Giachelli CM: Osteopontin promotes vascular cell adhesion and spreading and is chemotactic for smooth muscle cells in vitro. Circ Res 1994;74:214–24PubMedGoogle Scholar
  85. Liaw L, Lindner V, Schwartz SM, Chambers AF, Giachelli CM: Osteopontin and beta 3 integrin are coordinately expressed in regenerating endothelium in vivo and stimulate Arg-Gly-Asp-dependent endothelial migration in vitro. Circ Res 1995;77:665–72 Liaw L, Lombardi DM, Almeida MM, Schwartz SM, deBlois D, Giachelli CM: Neutralizing antibodies directed against osteopontin inhibit rat carotid neointimal thickening after endothelial denudation. Arterioscler Thromb Vasc Biol 1997;17:188–93PubMedCrossRefGoogle Scholar
  86. Liaw L, Skinner MP, Raines EW, Ross R, Cheresh DA, Schwartz SM, Giachelli CM: The adhesive and migratory effects of osteopontin are mediated via distinct cell surface integrins. Role of alpha v beta 3 in smooth muscle cell migration to osteopontin in vitro. J. Clin Invest 1995;95:713–24PubMedCrossRefGoogle Scholar
  87. Lin TH, Aplin AE, Shen Y, Chen Q, Schaller M, Romer L, Aukhil I, Juliano RL: Integrin-mediated activation of MAP kinase is independent of FAK: evidence for dual integrin signaling pathways in fibroblasts. J Cell Biol 1997;136:1385–95PubMedCrossRefGoogle Scholar
  88. Linz W, Schaper J, Wiemer G, Albus U, Schoelkens BA: Ramipril prevents left ventricular hypertrophy with myocardial fibrosis without blood pressure reduction: a one year study in rats. Br J Pharmacol 1992;107:970–975PubMedGoogle Scholar
  89. Linz W, Schoelkens BA, Ganten D: Converting enzyme inhibition specificaly prevents the development and induces regression of cardiac hypertrophy in rats. Clin Exp Hypertens 1989;11:1325–1350CrossRefGoogle Scholar
  90. Lipfert L, Haimovich B, Schaller MD, Cobb BS, Parsons JT, Brugge JS: Integrin-dependent phosphorylation and activation of protein tyrosine kinase ppl25FAK in platelets. J Cell Biol 1992;119:905–912PubMedCrossRefGoogle Scholar
  91. Lopez C, Hoyer J, Wilson P, Waterhouse P, Denhardt D: Heterogeneity of osteopontin expression among nephrons in mouse kidneys and enhanced expression in sclerotic glomeruli. Lab Invest 1993;69:355–363PubMedGoogle Scholar
  92. MacLellan WR, Brand T, Schneider MD: Transforming growth factor-beta in cardiac ontogeny and adaptation. Circ Res 1993;73:783–91PubMedGoogle Scholar
  93. Mamuya WS, Brecher P: Fibronectin expression in the normal and hypertrophic rat heart. J. Clin Invest 1992;89:392–401PubMedCrossRefGoogle Scholar
  94. Mamuya WS, Chobanian A, Brecher P: Age related changes in fibronectin expression in spontaneously hypertensive Witstar-Kyoto and Witstar rat hearts. Circ Res 1992;71:1341–1350PubMedGoogle Scholar
  95. Matsubara H, Kanakasi M, Murasawa S, Tsukaguchi Y, Nio Y, Inada M: Differential gene expression and regulation of angiotensin II receptor subtypes in rat cardiac fibroblasts and cardiomyocytes in culture. J Clin Invest 1994;93:1592–1601PubMedCrossRefGoogle Scholar
  96. Matsuno H, Stassen JM, Vermylem J, Deckmyn H: Inhibition of integrin function by a cyclic RGD-containing peptide prevents neointima formation. Circulation 1994;90:2203–2206PubMedGoogle Scholar
  97. McKee MD, Glimcher MJ, Nanci A: High-resolution immunolocalization of osteopontin and osteocalcin in bone and cartilage during endochondral ossification in the chicken tibia. Anat Rec 1992;234:479–92PubMedCrossRefGoogle Scholar
  98. Miyamoto S, Teramoto H, Coso OA, Gutkind JS, Burbelo PD, Akiyama SK, Yamada KM: Integrin function: molecular hierarchies of cytoskeletal and signaling molecules. J Cell Biol. 1995;131:791–805PubMedCrossRefGoogle Scholar
  99. Miyauchi A, Alvarez J, Greenfield EM, Teti A, Grano M, Colucci S, Zambonin Zallone A, Ross FP, Teitelbaum SL, Cheresh D, Hruska KA: Recognition of osteopontin and related peptides by an alpha v beta 3 integrin stimulates immediate cell signals in osteoclasts. J Biol Chem 1991;266:20369–74PubMedGoogle Scholar
  100. Molkentin JD, Olson EN: GAT A4: A novel transcritional regulator of cardiac hypertrophy? Circulation 1997;96:3833–5PubMedGoogle Scholar
  101. Mooney DJ, Langer R, Ingber DE: Cytoskeletal filament assembly and the control of cell spreading and function by extracellular matrix. J Cell Sci 1995; 108:2311–20PubMedGoogle Scholar
  102. Morgan HE, Baker KM: Cardiac hyperthrophy. Circulation 1991;83:13–25PubMedGoogle Scholar
  103. Murry C, Giachelli C, Schwartz S, Vracko R: Macrophages express osteopontin during repair of myocardial necrosis. Am J Pathol 1994,145:1450–1462PubMedGoogle Scholar
  104. Neuß M, Regitz-Zagrosek V, Fleck E: Human cardiac fibroblasts express an angiotensin receptor with unusual binding characteristics. Biophys Biochem Res Comm 1994;204 (3):1334–1339CrossRefGoogle Scholar
  105. O’Brien K, Kuusisto J, Relchenbach D, Ferguson M, Giachelli C, Alpers C, Otto C: Osteopontin is expressed in human aortic valvular lesions. Circulation 1995;92:2029–32Google Scholar
  106. Palmer JN, Hartogensis WE, Patten M, Fortuin FD, Long CS: Interleukin-1 beta induces cardiac myocyte growth but inhibits cardiac fibroblast proliferation in culture. J Clin Invest 1995;95:2555–64PubMedCrossRefGoogle Scholar
  107. Pennica D, King KL, Shaw KJ, Luis E, Rullamas J, Luoh SM, Darbonne WC, Knutzon DS, Yen R, Chien KR: Expression cloning of cardiotrophin 1, a cytokine that induces cardiac myocyte hypertrophy. Proc Natl Acad Sci USA 1995;92:1142–6PubMedCrossRefGoogle Scholar
  108. Pfeffer MA, Braunwald E, Moye LA, Basta L, Brown E, Jr., Cuddy TE, Davis BR, Geltman EM, Goldman S, Flaker GC: Effect of Captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial. The SAVE Investigators. N Engl J Med 1992;327:669–77PubMedCrossRefGoogle Scholar
  109. Pitt B, Segal R, Martinez FA, Meurers G, Cowley AJ, Thomas I, Deedwania PC, Ney DE, Snavely DB, Chang PI: Randomised trial of losartan versus Captopril in patients over 65 with heart failure (Evaluation of Losartan in the Elderly Study, ELITE) Lancet 1997;349:747–52PubMedCrossRefGoogle Scholar
  110. Plopper GE, McNamee HP, Dike LE, Bojanowski K, Ingber DE: Convergence of integrin and growth factor receptor signaling pathways within the focal adhesion complex. Mol Biol Cell 1995;6:1349–65PubMedGoogle Scholar
  111. Pollack S, Linnemeyer P, Gill S: Induction of Osteopopntin mRNA expression during activation of murine NK cells. J Leukocyte Biol 1994;55:398–400PubMedGoogle Scholar
  112. Regan CP, Anderson PG, Bishop SP, Berecek KH: Captopril prevents vascular and fibrotic changes but not cardiac hypertrophy in aortic-banded rats. Am J Physiol 1996;Google Scholar
  113. Regan CP, Anderson PG, Bishop SP, Berecek KH: Pressure-independent effects of ATI-receptor antagonism on cardiovascular remodeling in aortic-banded rats. Am J Physiol 1997;Google Scholar
  114. Regitz-Zagrosek V, Fielitz J, Dreysse R, Hildebrandt AG,Fleck E: Angiotensin receptor type 1 mRNA in human right ventricular endomyocardial biopsies: downregulation in heart failure. Cardiovasc Res 1997;35:99–105PubMedCrossRefGoogle Scholar
  115. Regitz-Zagrosek V, Friedel N, Heymann A, Bauer P, Neuss M, Rolfs A, Steffen C, Hildebrandt A, Hetzer R, Fleck E: Regulation, chamber localization, and subtype distribution of angiotensin II receptors in human hearts. Circulation 1995;91:1461-PubMedGoogle Scholar
  116. Regitz-Zagrosek V, Neuss M, Fleck E: Effects of angiotensin receptor antagonists in heart failure: clinical and experimental aspects. Eur Heart J 1995;Google Scholar
  117. Regitz-Zagrosek V, Neuss M, Holzmeister J, Warnecke C, Fleck E: Molecular biology of angiotensin receptors and their role in human cardiovascular disease. J Mol Med 1996;74:233–51PubMedCrossRefGoogle Scholar
  118. Sadoshima J, Izumo S: Mechanical stretch rapidly activates multiple signal transduction pathways in cardiac myocytes: potential involvement of an autocrine/paracrine mechanism. EMBO J 1993;12:1681–92PubMedGoogle Scholar
  119. Sadoshima J, Izumo S: Molecular characterization of angiotensin II-induced hypertrophy of cardiac myocytes and hyperplasia of cardiac fibroblasts. Critical role of the ATI receptor subtype. Circ Res 1993;73:413–23PubMedGoogle Scholar
  120. Sadoshima J, Izumo S: Signal transduction pathways of angiotensin II—induced c-fos gene expression in cardiac myocytes in vitro. Roles of phospholipid-derived second messengers. Circ Res 1993;73:424–38PubMedGoogle Scholar
  121. Sadoshima J, Xu Y, Slayter HS, Izumo S: Autocrine release of angiotensin II mediates stretch-induced hypertrophy of cardiac myocytes in vitro. Cell 1993;75:977–84PubMedCrossRefGoogle Scholar
  122. Sakai S, Miyauchi T, Kobayashi M, Yamaguchi I, Goto K, Sugishita Y: Inhibition of myocardial endothelin pathway improves long-term survival in heart failure. Nature 1996;384:353–355PubMedCrossRefGoogle Scholar
  123. Sakai S, Miyauchi T, Sakurai T, Kasuya Y, Ihara M, Yamaguchi I, Goto K, Sugishita Y: Endogeneous endothelin-1 participates in the maintainance of cardiac function in rats with congestive heart failure: marked increase in endothelin-1 production in the failing heart. Circulation 1996;93:1214–1222PubMedGoogle Scholar
  124. SAVE-Investigators: Effect of Captopril on morbidity and mortality in patients with left ventricular dysfunction after myocardial infarction, results of the survival and ventricular enlargement trial. N.Engl J.Med. 1992;327:669–677CrossRefGoogle Scholar
  125. Schieffer B, Wirger A, Meybrunn M, Seitz S, Holtz J, Riede U, Drexler H: Comparative effects of chronic angiotensin-converting enzyme inhibition and angiotensin II type I receptor blockade on cardiac remodeling after myocardial infarction in the rat. Circulation 1994;89:2273–2282PubMedGoogle Scholar
  126. Schmieder RE, Martus P, Klingbeil A: Reversal of left ventricular hypertrophy in essential hypertension: a meta-analysis of randomized double-blind studies. JAMA 1996;275:1507–1513 Schorb W, Booz G, Dostal K, Conrad K, Chang K, Baker K: Angiotensin II is mitogenic in neonatal rat cardiac fibroblasts. Circ Res 1993;72:1245–1254Google Scholar
  127. Schorb W, Conrad KM, Singer HA, Dostal DE, Baker KM: Angiotensin II is a potent stimulator of MAP-kinase activity in neonatal rat cardiac fibroblasts. J Mol Cell Cardiol 1995;27:1151–60PubMedCrossRefGoogle Scholar
  128. Schorb W, Peeler TC, Madigan NN, Conrad KM, Baker KM: Angiotensin II-induced protein tyrosine phosphorylation in neonatal rat cardiac fibroblasts. J Biol Chem 1994;269:19626–32PubMedGoogle Scholar
  129. Schunkert H, Dzau V, Tang S, Hirsch A, Apstein A, Lorell B: Increased rat cardiac angiotensin converting enzyme activity and mRNA expression in pressure overload left ventricular hyperthrophy: effects on coronary resistance, contractility, and relaxation. J.Clin. Invest. 1990;86:1913–1920PubMedCrossRefGoogle Scholar
  130. Schunkert H, Sadoshima J, Cornelius T, Kagaya Y, Weinberg E O, Izumo S, Riegger G, Lorell BH: Angiotensin II-induced growth responses in isolated adult rat hearts. Evidence for load-independent induction of cardiac protein synthesis by angiotensin II. Circ Res 1995; 76: 489–97.PubMedGoogle Scholar
  131. Schunkert H, Weinberg E O, Bruckschlegel G, Riegger A J and Lorell B H. 1995. Alteration of growth responses in established cardiac pressure overload hypertrophy in rats with aortic banding. J Clin Invest 96: 2768–74.PubMedCrossRefGoogle Scholar
  132. Schwartz MA: Spreading of human endothelial cells on fibronectin or vitronectin triggers elevatio of intracellular free calcium. J. Biol Chem 1993;120:1003–1010Google Scholar
  133. Schwartz MA, Schaller MD, Ginsberg MH: Integrins: Emerging paradigms of signal transduction. Annu Rev Cell Dev Biol 1995;11:549–599PubMedCrossRefGoogle Scholar
  134. Senger D, Perruzzi C, Gracey C, Papadopoulos A, Tenen D: Secreted phosphoproteins associated with neoplastic transformation: close homoloy with plasma proteins cleaved during blood coagulation. Cancer Res. 1988;48:5770–5774PubMedGoogle Scholar
  135. Senger DR, Perruzzi CA, Papadopoulos Sergiou A, Van de Water L: Adhesive properties of osteopontin: regulation by a naturally occurring thrombin-cleavage in close proximity to the GRGDS cell-binding domain. Mol Biol. Cell 1994;5:565–74PubMedGoogle Scholar
  136. Shanahan CM, Cary NR, Metcalfe JC, Weissberg PL: High expression of genes for calcification-regulating proteins in human atherosclerotic plaques. J Clin Invest 1994;93:2393–402PubMedCrossRefGoogle Scholar
  137. Shubeita H, McDonough P, Harris A, Knowlton K, Glembotski C, Brown J, Chien K: Endothelin induction of inositol phospholipid hydrolysis, sarcomere assembly, and cardiac gene expression in ventricular hyperthrophy. J.Biol.Chem. 1990,265:7388–7345Google Scholar
  138. Sil P, Misono K, Sen S: Myotrophin in human cardiomyopathic heart. Circ Res 1993;73:98–108PubMedGoogle Scholar
  139. Simpson P, McGrath A, Savion S: Myocyte hyperthrophy in neonatal rat heart cultures and its regulation by serum and catecholamines. Circ Res 1982;51:787–801PubMedGoogle Scholar
  140. Singh K, Ballingand J, Fischer T, Smith T, Kelly R: Glucocorticoids increase osteopontin expression in cardiac myocytes and microvascular endothelial cells. J Biol Chem 1995;270:28471–28478PubMedCrossRefGoogle Scholar
  141. Singh R, Patarca R, Schwartz J, Singh P, Cantor H: definition of a specific interaction between early T-lymphocyte activation (Eta-1) protein and murine macrophages in vitro and its effect on macrophages in vivo. J.Exp.Med. 1990;171:1931–1942Google Scholar
  142. Smits JFM, Krimpen C, Regien G, Cleutjens JPM, Daemen MJAP: Angiotensin II receptor blockade after myocardial infarction in rats: effects on hemodynamics, myocardial DNA synthesis, and interstitial collagen content. J Cardiovasc Pharmacol 1992;20:772–778PubMedGoogle Scholar
  143. SOLVD: Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions. The SOLVD Investigators. N Engl J Med 1992;327:685–91CrossRefGoogle Scholar
  144. Soufer R, Wohlgelernter D, Vita NA, Amuchestegui M, Sostman HD, Berger HJ, Zaret BL: Intact systolic left ventricular function in clinical congestive heart failure. Am J Cardiol 1985;55:1032–6PubMedCrossRefGoogle Scholar
  145. Sun Y, Cleutjens JP, Diaz-Arias AA, Weber KT: Cardiac angiotensin converting enzyme and myocardial fibrosis in the rat [see comments]. Cardiovasc Res 1994;28:1423–32PubMedCrossRefGoogle Scholar
  146. Sun Y, Weber KT: Angiotensin II receptor binding following myocardial infarction in the rat. Cardiovasc Res 1994;28:1623–1628PubMedCrossRefGoogle Scholar
  147. Terracio L, Rubin K, Gullberg D, Balog E, Carver W, Jyring R, Borg TK: Expression of collagen binding integrins during cardiac development and hypertrophy. Circ Res 1991;68:734–44PubMedGoogle Scholar
  148. Tezuka K, Sato T, Kamioka H, Nijweide PJ, Tanaka K, Matsuo T, Ohta M, Kurihara N, Hakeda Y, Kumegawa M: Identification of osteopontin in isolated rabbit osteoclasts. Biochem Biophys Res Commun 1992; 186:911–7PubMedCrossRefGoogle Scholar
  149. Tremble P, Damsky CH, Werb Z: Components of the nuclear signaling cascade that regulate collagenase gene expression in response to integrin-derived signals. J Cell Biol 1995;129:1707–20PubMedCrossRefGoogle Scholar
  150. Vejlstrup NG, Bouloumie A, Boesgaard S, Andersen CB, Nielsen-Kudsk JE, Mortensen S A, Kent J D, Harrison DG, Busse R, Aldershvile J: Inducible nitric oxide synthase (iNOS) in the human heart: expression and localization in congestive heart failure. J Mol Cell Cardiol 1998; 30: 1215–23.PubMedCrossRefGoogle Scholar
  151. Villareal F, Kim J, Ungab G, Printz M, Dillmann W: Identification of functional angiotensin II receptors on rat cardiac fibroblasts. Circulation 1993;88:2849–2861Google Scholar
  152. Weber KT, Janicki J, Shroff S, Pick R, Chen R, Bashey R: Collagen remodeling of the pressure-overloaded, hyperthrophied non-human primate myocardium. Circ Res 1988;62:757–765PubMedGoogle Scholar
  153. Weber KT: Cardiac Interstitium. In: Heart Failure — Scientific principles and clinical practice. Edited by Poole-Wilson, Colucci, Massie, Chatterjee and Coats. Churchill Livingstone, New Yorck 1997;pp 13–31Google Scholar
  154. Weber KT: Extracellular matrix remodeling in heart failure. A role for de novo angiotensin II generation. Circulation 1997;96:4065–4082PubMedGoogle Scholar
  155. Weber KT, Sun Y, Tyagi SC, Cleutjens JP: Collagen network of the myocardium: function, structural remodeling and regulatory mechanisms. J Mol Cell Cardiol 1994;26:279–92PubMedCrossRefGoogle Scholar
  156. Weinberg EO, Lee MA, Weigner M, Lindpaintner K, Bishop SP, Benedict CR, Ho KK, Douglas PS, Chafizadeh E, Lorell BH: Angiotensin ATI receptor inhibition. Effects on hypertrophic remodeling and ACE expression in rats with pressure-overload hypertrophy due to ascending aortic stenosis. Circulation 1997;95:1592–600PubMedGoogle Scholar
  157. Williams EB, Halpert L, Wickline S, Davison G, Parks W, Rottman J: Osteopontin expression is increased in the heritable cardiomyopathy of Syrian hamsters. Circulation 1995;92:705–709PubMedGoogle Scholar
  158. Yamazaki T, Komuro I, Kudoh S, Zou Y, Shiojima I, Hiroi Y, Mizuno T, Maemura K, Aikawa R, Takano H, Yazaki Y: Endothelin-1 is involved in mechanical stretchinduced cardiomyocyte hypertrophy. Jbiol Chem l996;211:3221–3228Google Scholar
  159. Yamazaki T, Yazaki Y: Is there major involvement of the renin-angiotensin system in cardiac hypertrophy? Circ. Res. 1997;81:639–642PubMedGoogle Scholar
  160. Yue TL, McKenna PJ, Ohlstein EH, Farach Carson MC, Butler WT, Johanson K, McDevitt P, Feuerstein GZ, Stadel JM: Osteopontin-stimulated vascular smooth muscle cell migration is mediated by beta 3 integrin. Exp Cell Res 1994;214:459–64PubMedCrossRefGoogle Scholar
  161. Zachary I, Sinnett-Smith J, Turner CE, Rozengurt E: Bombesin, vasopressin, and endothelin rapidly stimulate tyrosine phosphorylation of the focal adhesion-associated protein paxillin in Swiss 3T3 cells. J Biol Chem 1993;268:22060–5PubMedGoogle Scholar
  162. Zierhut W, Zimmer HG, Gerdes AM: Effect of angiotensin converting enzyme inhibition on pressure-induced left ventricular hypertrophy in rats. Circ Res 1991;69:609–17PubMedGoogle Scholar

Copyright information

© Steinkopff Verlag Darmstadt 2000

Authors and Affiliations

  • Kristof Graf
    • 1
  1. 1.Klinik für Innere Medizin - KardiologieDeutsches Herzzentrum BerlinBerlinDeutschland

Personalised recommendations